The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
The company is less than 12 months old. Its public track record is still too short for a reliable bankruptcy probability.
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. Without a bankruptcy probability, the company's Checked score rests on these figures.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1032155323
Incorporation
Founding capital of €1,000, 100 shares · Founder: Name hiddenVisible after signing in · Appointment: Hidden nameVisible after signing in (director) · published on 29-12-2025 · Gazette deed
First establishment
Emile Idiersstraat 13, Auderghem
“La société a pour objet l'exercice de l'art de guérir, et plus précisément dans…” (deed in French)From the articles, 10 activitiesNo NACE code in the KBO yet
DYDASK is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show negative equity (-€1,445) and a net result of -€2,445.
The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
micro format, filed on 05-06-2026, 56 days before the deadline
Abbreviated and micro format
Small companies may file abbreviated or micro-format accounts. They often leave out revenue and other detail. The law allows it, so it is not missing data.
A company files its annual accounts with the National Bank no later than seven months after its financial year ends. Repeated late filing is a warning sign.
per financial year, computed from the annual accounts
Line
Trend
2025
-1,445
The ratios are withheld because a balance sheet total of €998 is too small for a meaningful ratio.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on DYDASK
Equity is negative. Debt (€2,442) exceeds the balance-sheet total (€998).
Board & ownership
Board
Directors
Many board changes in a short time are a reason to keep a close eye on the company.
1 director, since incorporation
Name after signing inVisible after signing in
Director (not named in the articles)
appointed by deed of 29-12-2025term without a fixed end
Each bar is one period in a role, from appointment to resignation or to today. An open left edge means the mandate began before its first mention. An open right edge means the mandate ended without a stated end date.
1 name, the dashed line is today
2025202620272028
Name hiddenVisible after signing in Director (not named in the articles)
Board
Mandates as a list
Hidden nameVisible after signing in
Director (not named in the articles), appointed by deed of 29-12-2025, still in office
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
Name after signing inVisible after signing in100 shares (100%) · €1,000 in cash
Network & group
No group
DYDASK has no parent and no holdings in its annual accounts. Name hiddenVisible after signing in is the only director. DYDASK shares no director with another company.
At the same address
At the same address
These companies are registered at the seat of DYDASK today. That says who is based there, not who owns the building.
Annual accounts 2025 filedPDFmicro format · 56 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:1032155323
2025
IncorporationFounding capital of €1,000, 100 shares · Founder: Name after signing inVisible after signing in · Appointment: Name hiddenVisible after signing in (director) · published on 29-12-20256 points ▸
Founder, Hidden nameVisible after signing in
Founding capital, €1,000, 100 shares
100 shares
Registered office clause, Rue Emile Idiers 13, 1160 Auderghem
Board rule, 1
Director appointment, Name after signing inVisible after signing in (director (not named in the articles))
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
PurposeThe purpose describes the activities the company may carry out under its articles.
“La société a pour objet l'exercice de l'art de guérir, et plus précisément dans le cadre de la néphrologie qui consiste en un diagnostic et…”
10 activities
La société a pour objet l'exercice de l'art de guérir, et plus précisément dans le cadre de la néphrologie qui consiste en un diagnostic et traitement de pathologies liés à la spécialisation médicale, en ce compris des consultations, suivi des patients, ainsi tout acte technique propre à la profession médicale, et toute mesure préventive.
En complément à ces premières activités, il procédera à tout traitement chirurgical de pathologies de la sphère néphrologie diagnostiquées en consultation ou aux urgences hospitalières si cela s'avère nécessaire.
Il travaillera en étroite collaboration avec d'autres spécialistes comme les urologues, les cardiologues et les médecins généralistes.
Cet objet comprend la mise à disposition des moyens nécessaires aux médecins pour exercer leur art au sein de la société.
La société pourra procéder à toutes les recherches et toutes études en rapport avec son objet principal, s'occuper de la recherche et du développement de techniques scientifiques favorisant un diagnostic précis.
Elle pourra dispenser tous avis, donner tous cours et conférences et organiser tous séminaires dans le cadre de la pratique médicale.
La société pourra, en Belgique, exercer toute autre activité susceptible de favoriser son objet, tant en matière indépendante que dans le cadre de contrats avec des établissements de soins ou des confrères médecins, dans le respect du Code de Déontologie Médicale.
La société pourra également, s'intéresser de toutes façons dans toutes sociétés ou entreprises existantes ou à créer, dont l'objet serait similaire, analogue ou connexe au sien.
La société pourra poser tout acte nécessaire et/ou indispensable à l'accomplissement de son objet et plus particulièrement toute transaction mobilière ou immobilière ou de valorisation de patrimoine immobilier concernant les locaux médicaux, l'achat du matériel médical et non médical, l'engagement du personnel administratif, soignant, pratiquant ou appelé à pratiquer dans la société.
La société pourra d'une façon générale accomplir toutes opérations se rapportant directement ou indirectement à la réalisation de son objet, sans en modifier la vocation médicale.